EurekAlert!, a service of AAAS
Home About us
Advanced Search
26-May-2015 21:53
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources


News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 701-725 out of 776.

<< < 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 > >>

Public Release: 2-Sep-2013
The future of biodiversity publishing
The EU e-Infrastructure coordination project "pro-iBiosphere", targeting the preparation of a European Open Biodiversity Knowledge Management System, makes thirteen recommendations to enhance the publication process to make biodiversity data accessible, computable and re-usable.

Contact: Donat Agosti
Pensoft Publishers

Public Release: 2-Sep-2013
Recommendations on how to move the naming of organisms from paper and on to the Internet
The EU e-Infrastructure coordination project "pro-iBiosphere", targeting the preparation of a European Open Biodiversity Knowledge Management System, makes ten recommendations to increase the adoption of digital workflows in the biodiversity domain.

Contact: Dr. Quentin Groom
Pensoft Publishers

Public Release: 30-Aug-2013
2013 MSA Coalition Annual Conference
CARRE Foundation selects TGen for unprecedented research into causes of multiple system atrophy
Under the banner, "Quest to Cure MSA in honor of Rex Griswold," the Translational Genomics Research Institute today was tapped to conduct the world's most in-depth genomic investigation into the causes of MSA. The project is funded by a $100,000 grant from the CARRE Foundation, part of CSP Business Media. MSA was selected as the beneficiary of a 2013 CARRE Foundation fundraising event in honor of Nestle's Rex Griswold.
Charitable Alliance of Restaurant and Retail Executives Foundation

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 29-Aug-2013
Young whoopers stay the course when they follow a wise old bird
How do birds find their way on migration? Is their route encoded in their genes, or learned? Working with records from a long-term effort to reintroduce critically endangered whooping cranes in the Eastern US, University of Maryland-led researchers found these long-lived birds learn the route from older cranes, and get better at it with age.
National Science Foundation, LOEWE Programme, Robert Bosch Foundation

Contact: Heather Dewar
University of Maryland

Public Release: 29-Aug-2013
Journal of Clinical Investigation
Tracking Huntington's disease through brain metabolism
In this issue of the Journal of Clinical Investigation, David Eidelberg and colleagues at the Feinstein Institute of Medical Research, evaluated changes in the brain metabolism of a small group of preclinical HD carriers over the course of seven years and identified a metabolic network that is associated with HD progression. Measurable increases in the activity of this network were predictive of time to symptom onset.
National Institutes of Health, CHDI Foundation Inc.

Contact: Corinne Williams
Journal of Clinical Investigation

Public Release: 29-Aug-2013
Compounds point the way to cancer's dependencies
The Broad Institute's Center for the Science of Therapeutics today announced the launch of its Cancer Therapeutics Response Portal -- a critical resource for advancing the discovery of potential cancer drugs matched to the patient populations most likely to benefit from them. The portal contains more than 70,000 connections between compound sensitivities and genetic or lineage features of cancer cell lines -- creating a public resource for finding therapeutically exploitable vulnerabilities in different cancer types.
Cancer Target Discovery and Development Network

Contact: Nicole Davis
Broad Institute of MIT and Harvard

Public Release: 27-Aug-2013
Journal of Clinical Investigation
JCI early table of contents for Aug. 27, 2013
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Aug. 27, 2013, in the JCI: Hearing loss associated with a lack of cell-cell junctions, Cancerous cells from donor kidney linked to recipient skin cancer, A strategy for combating drug-resistant cancers, Protease inhibitor resistance involves multiple stages of the HIV-1 life cycle, Origin of a hereditary east Texas bleeding disorder, and more.
National Institutes of Health, Région Ile de France, Deafness Research Foundation, NRPB, National Security Council, Howard Hughes Medical Institute

Contact: Corinne Williams
Journal of Clinical Investigation

Public Release: 26-Aug-2013
American Journal of Human Genetics
Researchers develop software tool for cancer genomics
Researchers at the Medical College of Wisconsin and the National Cancer Institute have developed a new bioinformatics software tool designed to more easily identify genetic mutations responsible for cancers.

Contact: Maureen Mack
Medical College of Wisconsin

Public Release: 26-Aug-2013
Study offers insight into the origin of the genetic code, team reports
An analysis of enzymes that load amino acids onto transfer RNAs -- an operation at the heart of protein translation -- offers new insights into the evolutionary origins of the modern genetic code, researchers report. Their findings appear in the journal PLOS ONE.
National Science Foundation, U.S. Department of Agriculture

Contact: Diana Yates
University of Illinois at Urbana-Champaign

Public Release: 25-Aug-2013
Nature Methods
New tool enhances the search for genetic mutations
Reed Cartwright, a researcher at Arizona State University's Biodesign Institute, along with colleagues at ASU, Washington University and the Wellcome Trust Sanger Institute, Cambridge, UK, report on a new software tool known as DeNovoGear, which uses statistical probabilities to help identify mutations and more accurately pinpoint their source and their possible significance for health.

Contact: Joseph Caspermeyer
Arizona State University

Public Release: 25-Aug-2013
Nature Genetics
Scientists pinpoint 105 additional genetic errors that cause cystic fibrosis
Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis (CF), it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.
NIH/National Institute of Diabetes and Digestive and Kidney, Cystic Fibrosis Foundation Therapeutics, Cystic Fibrosis Foundation, Fundação para a Ciência e a Tecnologia

Contact: Catherine Kolf
Johns Hopkins Medicine

Public Release: 21-Aug-2013
Nature Biotechnology
Genome researchers at Bielefeld University decode the hamster genome
Genome researchers from Bielefeld University's Center for Biotechnology headed by Professor Dr. Alfred Pühler have succeeded in sequencing the genome of the Chinese hamster. The Chinese hamster supplies the cell cultures used by the pharmaceutical industry to produce biopharmaceutical products such as antibodies used in medicine. This costly project was only possible thanks to a cooperation between Bielefeld University and its international project partners. The researchers have now published their results in the internationally renowned scientific journal 'Nature Biotechnology'.

Contact: Dr. Alfred Pühler
Bielefeld University

Public Release: 15-Aug-2013
Journal of Clinical Investigation
JCI early table of contents for Aug. 15, 2013
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Aug. 15, 2013, in the JCI: Biomarkers predict time to ovarian cancer recurrence, A molecule involved in development of chronic obstructive pulmonary disease, Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis and many more.

Contact: Corinne Williams
Journal of Clinical Investigation

Public Release: 14-Aug-2013
Cancer's origins revealed
Scientists have provided the first comprehensive genomic map of mutational processes that drive tumour development. Together, these mutational processes explain the majority of mutations found in 30 of the most common cancer types.

Contact: Aileen Sheehy
Wellcome Trust Sanger Institute

Public Release: 11-Aug-2013
NIH-funded study discovers new genes for childhood epilepsies
A genetic study of childhood epilepsies has linked two new genes to severe forms of disease and provides a novel strategy for identifying therapy targets. The results suggest this may be a highly effective way to find and confirm many disease-causing gene mutations.
NIH/National Institute of Neurological Disorders and Stroke, Finding a Cure for Epilepsy and Seizures, Richard Thalheimer Philanthropic Fund

Contact: Christopher Thomas
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 8-Aug-2013
American Journal of Human Genetics
Genetic evidence shows recent population mixture in India
Researchers have found that modern-day India is the result of recent population mixture among divergent demographic groups.
National Institutes of Health, National Science Foundation, UKIERI Major Award, Network Project

Contact: David Cameron
Harvard Medical School

Public Release: 6-Aug-2013
$20,000 Arizona Community Foundation grant helps fund TGen education
The Translational Genomics Research Institute (TGen) received another boost today for Science, Technology, Engineering and Math education with a $20,000 grant from the Arizona Community Foundation. TGen's Pathogen Genomics Division (TGen North) in Flagstaff secured the grant for the research institute's TGen2School program. At TGen North, some of the world's top experts study disease-causing microorganisms, including everything from valley fever to MRSA and even anthrax and plague.
Arizona Community Foundation

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 5-Aug-2013
Annals of Internal Medicine
NYU Langone researchers offer new model, helping clinicians prioritize recommended preventive
With physicians facing increasing demands on their time, it can be extremely difficult to prioritize which preventive care methods should be used for their patients. Now, two researchers at NYU Langone Medical Center have developed a mathematical model that will save time, lead to enhanced care, and potentially save lives.
New York University School of Medicine

Contact: Lorinda Klein
NYU Langone Medical Center / New York University School of Medicine

Public Release: 4-Aug-2013
Nature Chemical Biology
Researchers dismantle bacteria's war machinery
This is a veritable mechanics of aggression on the nanoscale. Certain bacteria, including Staphylococcus aureus, have the ability to deploy tiny darts. This biological weapon kills the host cell by piercing the membrane. Researchers at EPFL have dismantled, piece by piece, this intriguing little machine. Published in Nature Chemical Biology, this discovery offers new insight into the fight against pathogens that are increasingly resistant to antibiotics.

Contact: Matteo Dal Peraro
Ecole Polytechnique Fédérale de Lausanne

Public Release: 2-Aug-2013
Wired for change
A study of gene expression led by scientists at the EMBL-European Bioinformatics Institute and the University of Cambridge has revealed the first steps of evolution in gene regulation in mice. Published in the journal Cell, the research has implications for the study of differences in gene regulation between people.
European Research Council, Marie Curie Re-Integration Award, EMBO Young Investigator Programme

Contact: Sonia Furtado Neves
European Molecular Biology Laboratory

Public Release: 1-Aug-2013
How 'junk DNA' can control cell development
Researchers from the Gene and Stem Cell Therapy Program at Sydney's Centenary Institute have confirmed that, far from being "junk," the 97 percent of human DNA that does not encode instructions for making proteins can play a significant role in controlling cell development. And in doing so, the researchers have unravelled a previously unknown mechanism for regulating the activity of genes, increasing our understanding of the way cells develop and opening the way to new possibilities for therapy.
Centenary Institute

Contact: Tamzin Byrne
Centenary Institute

Public Release: 1-Aug-2013
Targeted therapy identified for protein that protects and nourishes cancer
UT MD Anderson scientists identify the first targeted therapy to block Skp2, which suppresses a cellular defense against cancer and activates glycolysis to feed tumors. The drug restores the senescence program and stifles glycolysis to thwart tumor progression.
NIH/National Cancer Institute, American Cancer Society, Susan G. Komen for the Cure

Contact: Scott Merville
University of Texas M. D. Anderson Cancer Center

Public Release: 1-Aug-2013
New designer compound treats heart failure by targeting cell nucleus
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discovery relevant to the understanding and treatment of heart failure -- a leading cause of death worldwide. The team discovered a new molecular pathway responsible for causing heart failure and showed that a first-in-class prototype drug, JQ1, blocks this pathway to protect the heart from damage.
National Institutes of Health

Contact: Jessica Studeny
Case Western Reserve University

Public Release: 31-Jul-2013
Stem Cells
Computational biology: Cells reprogrammed on the computer
Scientists at the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have developed a model that makes predictions from which differentiated cells -- for instance skin cells -- can be very efficiently changed into completely different cell types -- such as nerve cells, for example. This can be done entirely without stem cells. These computer-based instructions for reprogramming cells are of huge significance for regenerative medicine. The LCSB researchers present their results today in the prestigious scientific journal "Stem Cells".

Contact: Britta Schlüter
University of Luxembourg

Public Release: 31-Jul-2013
Wonders of nature inspire exotic man-made materials
In this month's edition of Physics World, a group of physicists describe how unique structures in the natural world are inspiring scientists to develop new types of materials with unprecedented properties.

Contact: Michael Bishop
Institute of Physics

Showing releases 701-725 out of 776.

<< < 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 > >>